Table 2. Annual Age-, Sex-, and Race-Specific Incidence Rate of Chilblains and COVID-19 Before and During the Pandemic.
Variable | 2020 Denominator | Chilblains incidence per 100 000 person-years | COVID-19 incidence per 1000 person-years (March-November 2020) | ||||
---|---|---|---|---|---|---|---|
Before the pandemic (April-December, 2016-2019) | During the pandemic (April-December, 2020) | ||||||
No. of cases | Incidence rate (95% CI)a | No. of cases | Incidence rate (95% CI)a | No. of cases | Incidence rate (95% CI)a | ||
Overall | 4 370 992 | 539 | 5.2 (4.8-5.6) | 780 | 28.6 (26.8-30.4) | 78 129 | 28.6 (28.4-28.8) |
Age, y | |||||||
0-12 | 603 032 | 46 | 3.7 (2.9-4.9) | 103 | 27.3 (22.9-32.6) | 6315 | 16.8 (16.4-17.1) |
13-19 | 354 595 | 78 | 9.1 (7.5-11.2) | 139 | 62.7 (53.9-73.0) | 5697 | 25.7 (25.1-26.3) |
20-39 | 1 249 917 | 128 | 4.4 (3.8-5.2) | 217 | 27.8 (24.6-31.4) | 29 483 | 37.7 (37.3-38.1) |
40-59 | 1 199 361 | 99 | 3.4 (2.9-4.1) | 164 | 21.9 (19.0-25.2) | 25 279 | 33.7 (33.3-34.1) |
≥60 | 964 087 | 188 | 7.5 (6.6-8.6) | 157 | 26.1 (22.6-30.1) | 11 355 | 18.8 (18.5-19.2) |
Sexb | |||||||
Female | 2 241 618 | 370 | 7.0 (6.3-7.6) | 464 | 33.1 (30.5-36.0) | 40 923 | 29.2 (29.0-29.5) |
Male | 2 129 374 | 169 | 3.3 (2.9-3.8) | 316 | 23.7 (21.5-26.3) | 37 206 | 28.0 (27.7-28.2) |
Race/ethnicity | |||||||
African American | 276 448 | 28 | 4.1 (2.9-5.7) | 20 | 11.6 (7.8-17.3) | 5040 | 29.2 (28.4-29.9) |
Asian American | 855 125 | 118 | 5.8 (4.9-6.9) | 227 | 42.5 (37.7-47.8) | 10 131 | 19.0 (18.6-19.3) |
Latinx | 922 117 | 69 | 3.1 (2.5-3.9) | 72 | 12.5 (10.1-15.4) | 36 005 | 62.5 (61.9-63.1) |
White | 1 734 060 | 289 | 6.6 (5.9-7.3) | 387 | 35.7 (32.6-39.1) | 19 439 | 17.9 (17.7-18.2) |
Other | 583 242 | 35 | 3.3 (2.4-4.5) | 74 | 20.3 (16.5-25.0) | 7514 | 20.6 (20.2-21.0) |
Denominators for prepandemic period based on January 1, 2018, enrollment and for pandemic period based on June 1, 2020, enrollment.
The number of patients who were nonbinary or transgender was too few to analyze. All differences between incidence rates were significant at P < .001.